Clinical Trial Update: MVA Post-Event: Administration Timing and Boost Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the timing of post-exposure MVA vaccination and booster dosing for smallpox, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• MVA (Modified Vaccinia Ankara) vaccine (Modified Vaccinia Ankara)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-09-19